Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.

@article{Chlebowski1990HydrazineSI,
  title={Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.},
  author={Rowan Chlebowski and Linda Bulcavage and Mary B Grosvenor and Ergun Oktay and J B Block and J S Chlebowski and Irma Ali and Robert M. Elashoff},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1990},
  volume={8 1},
  pages={9-15}
}
This randomized, prospective, placebo-controlled clinical trial compares the influence on nutritional status and survival of hydrazine sulfate with placebo addition to cisplatin-containing combination chemotherapy in patients with unresectable non-small-cell lung cancer (NSCLC). The trial consisted of 65 patients with advanced, unresectable NSCLC who had had no prior chemotherapy, were at least partially ambulatory (Eastern Cooperative Oncology Group [ECOG] performance status [PS] level 0-2… CONTINUE READING

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…